Clinical Trials Directory

Trials / Unknown

UnknownNCT04255940

2019-nCoV Outbreak and Cardiovascular Diseases

Impact of a Novel Coronavirus (2019-nCoV) Outbreak on Public Anxiety and Cardiovascular Disease Risk in China

Status
Unknown
Phase
Study type
Observational
Enrollment
12,000 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Cardiovascular events occurring after 2019-nCoV outbreak in Jinan were prospectively assessed by emergency physicians. We compared those events with events that occurred during the past 3 months and the same months of the last year.

Detailed description

This survey aims to assess whether the public anxiety from a novel coronavirus (2019-nCoV) outbreak increases cardiovascular disease risk in China. Cardiovascular events occurring after 2019-nCoV outbreak in Jinan were prospectively assessed by emergency physicians. We compared those events with events that occurred during the past 3 months and the same months of the last year.

Conditions

Timeline

Start date
2020-01-20
Primary completion
2020-04-30
Completion
2020-04-30
First posted
2020-02-05
Last updated
2020-02-05

Locations

12 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04255940. Inclusion in this directory is not an endorsement.

2019-nCoV Outbreak and Cardiovascular Diseases (NCT04255940) · Clinical Trials Directory